Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
93.64 USD | +0.69% | +3.70% | +1.87% |
Apr. 25 | Transcript : Blueprint Medicines Corporation - Special Call | |
Mar. 22 | Blueprint Medicines Insider Sold Shares Worth $2,188,265, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.87% | 5.84B | |
+2.17% | 42.75B | |
+47.70% | 41.61B | |
+12.45% | 41.34B | |
-12.36% | 26.59B | |
+7.72% | 25.49B | |
-22.96% | 18.12B | |
+30.55% | 12.24B | |
-2.00% | 11.76B | |
+8.09% | 11B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Blueprint Medicines Says Ayvakit Data in Indolent Systemic Mastocytosis Show Long-Term Efficacy, Safety